01-10-2026
India's pharmaceutical manufacturing sector is undergoing one of its most significant regulatory shifts in years. With the Revised Schedule M norms now enforced across drug manufacturing units, cleanroom contamination control has moved from a "good practice" to a hard compliance requirement. At the center of this shift is filtration — specifically, a growing number of manufacturers upgrading from H13 to H14 HEPA filters to meet stricter air cleanliness benchmarks.
If you manage a pharma production facility, an EPC project, or a cleanroom retrofit, understanding why this upgrade is happening — and what filter grade your facility actually needs — is now essential to passing audits and avoiding compliance penalties.
Revised Schedule M, notified under the Drugs and Cosmetics Rules, brings Indian pharmaceutical manufacturing standards closer to WHO-GMP benchmarks. It places direct emphasis on facility design, air handling systems, and particulate control — areas where HEPA filtration plays a central role.
Under these revised norms, manufacturers are expected to demonstrate documented, validated air cleanliness across production, packaging, and quality control zones. This means older HEPA installations that were "compliant enough" under previous norms are now being re-evaluated, and in many cases, upgraded.
Both H13 and H14 fall under the EN 1822 HEPA classification, but they differ significantly in filtration efficiency.
H13 HEPA Filter: Captures a minimum of 99.95% of particles at the Most Penetrating Particle Size (MPPS)
H14 HEPA Filter: Captures a minimum of 99.995% of particles at MPPS
This tenfold improvement in particle capture is why H14 is increasingly specified for critical pharma zones under revised compliance expectations.
H14 filters are typically required in:
Sterile injectable manufacturing areas
Aseptic filling zones
ISO Class 5 (Grade A) critical zones
Biosafety-sensitive production lines
H13 remains suitable for lower-criticality zones such as general production support areas and ISO Class 7–8 spaces, where it continues to meet GMP requirements.
Regulatory audits under Revised Schedule M now scrutinize filtration validation records more closely. Facilities without documented HEPA performance data — or with filters operating below required efficiency thresholds — face non-compliance flags.
Cleanroom classification under ISO 14644 requires filtration systems capable of maintaining specified particle counts consistently. As facilities push for tighter ISO Class 5 compliance in critical zones, H13 filters often fall short of sustaining classification over time, especially as they age.
Schedule M compliance also demands robust DOP/PAO (Dispersed Oil Particulate) leak testing and validation. H14 filters, when properly integrated with IQ/OQ/PQ documentation, provide a stronger compliance buffer and reduce the frequency of failed validation cycles.
The Mini Pleat HEPA Filter design offers a higher effective filtration area within a compact frame, making it ideal for facilities with limited ceiling or FFU housing space. Its tighter pleat spacing supports higher airflow with lower pressure drop — a practical advantage for pharma units retrofitting existing HVAC infrastructure.
Deep Pleat HEPA Filters are suited for larger air handling units and central HVAC systems where higher filtration capacity and longer service life are priorities. These are commonly specified in bulk drug manufacturing and larger production facilities.
Many Schedule M-driven upgrades involve retrofitting existing cleanroom infrastructure rather than new construction. This is where Custom Size HEPA Filters become critical — allowing manufacturers to upgrade filtration grade without redesigning duct work, FFU housings, or ceiling grid systems.
Beyond terminal filtration in cleanroom ceilings, HEPA Filters for HVAC systems play a supporting role in maintaining overall facility air quality — filtering recirculated and fresh air before it reaches critical zones. As Schedule M compliance extends scrutiny to entire HVAC air paths, manufacturers are also upgrading pre-filtration and HVAC-stage HEPA filters, not just terminal FFU-mounted units.
Sourcing decisions matter as much as filter grade selection. Working with HEPA Filter Manufacturers in India who manufacture directly — rather than trade or import — gives pharma facilities several compliance advantages:
Factory-tested filters with documented efficiency data
Faster turnaround for custom sizes needed in retrofit projects
Direct access to IQ/OQ/PQ documentation support for audits
Ability to customize frame material, gasket type, and filtration media per facility requirement
As a Cleanroom Air Filter Manufacturer, Rayshen Environmental designs and tests HEPA filters in-house, ensuring every unit shipped meets the efficiency and documentation standards pharma audits demand.
| Parameter | H13 HEPA Filter | H14 HEPA Filter |
| Efficiency at MPPS | ≥99.95% | ≥99.995% |
| EN 1822 Classification | H13 | H14 |
| Typical Application | ISO Class 7–8, general production | ISO Class 5, sterile/aseptic zones |
| Schedule M Suitability | Adequate for lower-criticality zones | Recommended for critical zones |
| Pressure Drop | Lower | Slightly higher |
| Common Use Case | Support areas, packaging zones | Injectable filling, biosafety-critical zones |
As a direct manufacturer, Rayshen Environmental Pvt Ltd provides Mini Pleat and Deep Pleat HEPA filters in both H13 and H14 grades, along with Custom Size HEPA Filters engineered for retrofit compatibility with existing FFU and HVAC systems. Every filter is factory-tested with DOP/PAO validation support and complete IQ/OQ/PQ documentation — helping pharma manufacturers move through Schedule M compliance upgrades without production downtime or costly redesign.
Explore our HEPA filter range: HEPA Filters | HEPA Filter Mini Pleat | Fan Filter Units
For a compliance assessment or custom quote, contact our team.
No. H14 is generally required for critical/aseptic zones (ISO Class 5), while H13 remains acceptable for lower-criticality support areas, subject to your facility's risk assessment and classification.
In most cases yes, provided housing dimensions match — this is why Custom Size HEPA Filters are commonly used for retrofit upgrades without replacing the entire FFU unit.
DOP/PAO leak testing is typically conducted at installation and then periodically (commonly every 6–12 months) as part of ongoing GMP validation, depending on internal SOPs and regulatory guidance.
Mini Pleat filters pack more filtration media into a compact frame, ideal for space-constrained retrofits. Deep Pleat filters suit larger HVAC applications requiring higher airflow capacity and extended service life.
Yes, Rayshen Environmental produces Custom Size HEPA Filters tailored to existing cleanroom infrastructure, avoiding the need for facility redesign during compliance upgrades.